Corixa was a biotechnology/pharmaceutical company based in Seattle,
Washington involved in the development of immunotherapeutics to combat autoimmune diseases, infectious diseases, and cancer.
- This article is about the biotech corporation. For
the style fly tying, see Fly
It was founded in 1994. It operated a
laboratory and production facility in Hamilton, Montana.
The name Corixa comes from the true bug (Insecta: Hemiptera:
Heteroptera) genus Corixa
(family Corixidae, Water boatman
), described by Geoffroy, in
On 12 July 2005, the European pharmaceuticals giant GlaxoSmithKline
completed the acquisition of
Corixa. GSK had formerly made use of the Corixa's MPL adjuvant
in some of their
On 31 March 2006, Corixa's doors closed after over 11 years in